{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:08Z","timestamp":1793836148864,"version":"4.6.1"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003363"],"award-info":[{"award-number":["82003363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073449"],"award-info":[{"award-number":["82073449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203930"],"award-info":[{"award-number":["82203930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203932"],"award-info":[{"award-number":["82203932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30790"],"award-info":[{"award-number":["2023JJ30790"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115282","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T17:59:46Z","timestamp":1691603986000},"page":"115282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Further insight into systemic sclerosis from the vasculopathy perspective"],"prefix":"10.1016","volume":"166","author":[{"given":"Hao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuotong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-8057","authenticated-orcid":false,"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10373","key":"10.1016\/j.biopha.2023.115282_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"10103","key":"10.1016\/j.biopha.2023.115282_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2023.115282_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat. Rev. Rheuma"},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41584-021-00683-2","article-title":"Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential","volume":"17","author":"Tsou","year":"2021","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.biopha.2023.115282_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm10194427","article-title":"Autoimmune rheumatic diseases and vascular function: the concept of autoimmune atherosclerosis","volume":"10","author":"Hedar","year":"2021","journal-title":"J. Clin. Med"},{"issue":"7\u20138","key":"10.1016\/j.biopha.2023.115282_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/10408363.2017.1394267","article-title":"The vascular endothelium: a regulator of arterial tone and interface for the immune system","volume":"54","author":"Khaddaj Mallat","year":"2017","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115282_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/annrheumdis-2018-213648","article-title":"Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis","volume":"77","author":"Soldano","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir. Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110189","article-title":"CXCL4 drives fibrosis by promoting several key cellular and molecular processes","volume":"38","author":"Affandi","year":"2022","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOR.0000000000000898","article-title":"Role of cellular senescence in the pathogenesis of systemic sclerosis","volume":"34","author":"Tsou","year":"2022","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.biopha.2023.115282_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2018.01383","article-title":"The role of endothelial progenitors in the repair of vascular damage in systemic sclerosis","volume":"9","author":"Del Papa","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib17","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","article-title":"Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases","volume":"99","author":"Piera-Velazquez","year":"2019","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.118.034165","article-title":"Antiangiogenic VEGF(165)b regulates macrophage polarization via S100A8\/S100A9 in peripheral artery disease","volume":"139","author":"Ganta","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib20","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res"},{"issue":"8","key":"10.1016\/j.biopha.2023.115282_bib21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3899\/jrheum.160791","article-title":"Evidence for a derangement of the microvascular system in patients with a very early diagnosis of systemic sclerosis","volume":"44","author":"Chora","year":"2017","journal-title":"J. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2023.115282_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2023.115282_bib23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3389\/fimmu.2018.01985","article-title":"A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis","volume":"9","author":"Thuan","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/14397595.2016.1206510","article-title":"Oxidative stress markers in blood in systemic sclerosis: a meta-analysis","volume":"27","author":"Luo","year":"2017","journal-title":"Mod. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10067-007-0769-9","article-title":"Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis","volume":"27","author":"Riccieri","year":"2008","journal-title":"Clin. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10067-005-0013-4","article-title":"Lipid peroxidation and trace elements in systemic sclerosis","volume":"25","author":"Tikly","year":"2006","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.biopha.2023.115282_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.metabol.2018.12.004","article-title":"The role of metabolism in the pathogenesis of systemic sclerosis","volume":"93","author":"Zhu","year":"2019","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.biopha.2023.115282_bib28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2006.067504","article-title":"Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis","volume":"66","author":"Servettaz","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2023.115282_bib29","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2147\/JIR.S409489","article-title":"The gut microbial metabolite trimethylamine N-Oxide is linked to specific complications of systemic sclerosis","volume":"16","author":"Stec","year":"2023","journal-title":"J. Inflamm. Res"},{"issue":"7","key":"10.1016\/j.biopha.2023.115282_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104669","article-title":"Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation","volume":"25","author":"Kim","year":"2022","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib31","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160244","article-title":"Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion","volume":"37","author":"Ma","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2023.115282_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fphys.2019.00866","article-title":"Trimethylamine N-oxide exacerbates cardiac fibrosis via activating the NLRP3 inflammasome","volume":"10","author":"Li","year":"2019","journal-title":"Front Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","article-title":"Targeted inhibition of gut microbial trimethylamine N-oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease","volume":"40","author":"Gupta","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","article-title":"Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/keac451","article-title":"Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis","volume":"62","author":"Jimenez","year":"2023","journal-title":"Rheumatol. (Oxf. )"},{"issue":"11","key":"10.1016\/j.biopha.2023.115282_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2020.02.009","article-title":"The profiles of miRNAs and lncRNAs in peripheral blood neutrophils exosomes of diffuse cutaneous systemic sclerosis","volume":"98","author":"Li","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2020.03.088","article-title":"Neutrophil-derived exosome from systemic sclerosis inhibits the proliferation and migration of endothelial cells","volume":"526","author":"Li","year":"2020","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib39","first-page":"208","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"Rongioletti","year":"2018","journal-title":"G Ital. Dermatol. Venereol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115282_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2019-216115","article-title":"Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosis","volume":"78","author":"Varga","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11926-019-0867-0","article-title":"Progress in understanding, diagnosing, and managing cardiac complications of systemic sclerosis","volume":"21","author":"Hung","year":"2019","journal-title":"Curr. Rheuma Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519894456","article-title":"Patterns of renal pathology in Chinese patients with systemic sclerosis undergoing renal biopsy at a tertiary medical center","volume":"48","author":"Cao","year":"2020","journal-title":"J. Int Med Res"},{"issue":"8","key":"10.1016\/j.biopha.2023.115282_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2023.115282_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092490","article-title":"Raynaud's phenomenon with focus on systemic sclerosis","volume":"11","author":"Maciejewska","year":"2022","journal-title":"J. Clin. Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","article-title":"Molecular genetic framework underlying pulmonary arterial hypertension","volume":"17","author":"Southgate","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00002-2022","article-title":"Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension","volume":"8","author":"Naranjo","year":"2022","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib49","first-page":"656","article-title":"A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J. Rheuma"},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib50","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"5 Suppl 62","key":"10.1016\/j.biopha.2023.115282_bib51","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin. Exp. Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib52","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejim.2008.10.011","article-title":"Systolic and diastolic function in patients with systemic sclerosis","volume":"20","author":"Poanta","year":"2009","journal-title":"Eur. J. Intern Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2023.115282_bib54","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.2147\/JIR.S373387","article-title":"Long-term efficacy and low adverse events of methylprednisolone pulses combined to low-dose glucocorticoids for systemic sclerosis: a retrospective clinical study of 10 years' follow-up","volume":"15","author":"Cheng","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-019-04806-9","article-title":"Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients","volume":"39","author":"Liu","year":"2020","journal-title":"Clin. Rheuma"},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib56","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","article-title":"The clinical relevance of sexual dysfunction in systemic sclerosis","volume":"14","author":"Bruni","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib57","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10067-007-0567-4","article-title":"The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis","volume":"26","author":"Ostojic","year":"2007","journal-title":"Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/039463200702000116","article-title":"Penile cutaneous temperature in systemic sclerosis: a thermal imaging study","volume":"20","author":"Merla","year":"2007","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2017.11.036","article-title":"The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon","volume":"17","author":"Herrick","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib60","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/jdv.16813","article-title":"The importance of skin manifestations, serology and nailfold (video)capillaroscopy in morphea and systemic sclerosis: current understanding and new insights","volume":"35","author":"Mostmans","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.autrev.2018.09.002","article-title":"Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: a newsworthy association","volume":"18","author":"Zanatta","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2023.115282_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pacs.2018.02.002","article-title":"Assessing nailfold microvascular structure with ultra-wideband raster-scan optoacoustic mesoscopy","volume":"10","author":"Aguirre","year":"2018","journal-title":"Photoacoustics"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2016.2027","article-title":"Dynamic optical coherence tomography capillaroscopy: a new imaging tool in autoimmune connective tissue disease","volume":"152","author":"Ring","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jid.2021.08.436","article-title":"Nailfold microvascular imaging by dynamic optical coherence tomography in systemic sclerosis: a case-controlled pilot study","volume":"142","author":"Abignano","year":"2022","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2023.115282_bib67","doi-asserted-by":"crossref","first-page":"43304","DOI":"10.1038\/srep43304","article-title":"Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis","volume":"7","author":"Schwaiger","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/annrheumdis-2016-210875","article-title":"Optical coherence tomography as a method for quantitative skin evaluation in systemic sclerosis","volume":"77","author":"Pires","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib69","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/eurheartj\/ehu014","article-title":"Coronary artery disease in systemic sclerosis not clinically apparent: findings from optical coherence tomography","volume":"35","author":"Bernelli","year":"2014","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib70","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1093\/rheumatology\/keab258","article-title":"Retinal microcirculation abnormalities in patients with systemic sclerosis: an explorative optical coherence tomography angiography study","volume":"60","author":"Carnevali","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/annrheumdis-2018-214541","article-title":"Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study","volume":"78","author":"Rothe","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"644","key":"10.1016\/j.biopha.2023.115282_bib72","doi-asserted-by":"crossref","first-page":"eabm8059","DOI":"10.1126\/scitranslmed.abm8059","article-title":"Enabling precision monitoring of psoriasis treatment by optoacoustic mesoscopy","volume":"14","author":"Hindelang","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"14","key":"10.1016\/j.biopha.2023.115282_bib73","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1364\/OL.38.002472","article-title":"Raster-scan optoacoustic mesoscopy in the 25\u2013125\u2009MHz range","volume":"38","author":"Omar","year":"2013","journal-title":"Opt. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clindermatol.2021.12.001","article-title":"Optoacoustic imaging and potential applications of raster-scan optoacoustic mesoscopy in dermatology","volume":"40","author":"Messas","year":"2022","journal-title":"Clin. Dermatol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115282_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41584-021-00685-0","article-title":"Detection of microvascular changes in systemic sclerosis and other rheumatic diseases","volume":"17","author":"Cutolo","year":"2021","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib76","doi-asserted-by":"crossref","first-page":"16444","DOI":"10.1038\/s41598-020-73319-2","article-title":"Three-dimensional optoacoustic imaging of nailfold capillaries in systemic sclerosis and its potential for disease differentiation using deep learning","volume":"10","author":"Nitkunanantharajah","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5114\/pdia.2014.40653","article-title":"Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients","volume":"31","author":"Waszczykowska","year":"2014","journal-title":"Post. Dermatol. Alergol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mvr.2010.04.006","article-title":"Digital laser doppler flowmetry may discriminate \"limited\" from \"diffuse\" systemic sclerosis","volume":"80","author":"Grattagliano","year":"2010","journal-title":"Micro Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semarthrit.2019.08.007","article-title":"The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: a systematic review","volume":"50","author":"Melsens","year":"2020","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib80","first-page":"373","article-title":"Early sign of microangiopathy in systemic sclerosis: the significance of cold stress test in dynamic laser Doppler flowmetry","volume":"71","author":"Yu","year":"2019","journal-title":"Clin. Hemorheol. Micro"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib81","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13672","article-title":"Predictive value of laser speckle contrast analysis in systemic sclerosis. A systematic review and pilot study","volume":"52","author":"Vanhaecke","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib82","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/rheumatology\/keaa514","article-title":"Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis","volume":"60","author":"Gigante","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"8","key":"10.1016\/j.biopha.2023.115282_bib83","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.autrev.2018.01.023","article-title":"Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients","volume":"17","author":"Cutolo","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib84","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/annrheumdis-2013-203514","article-title":"Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients","volume":"73","author":"Ruaro","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5114\/ada.2021.104286","article-title":"Correlation between the infrared thermogram and microvascular abnormalities of the nailfold in patients with systemic sclerosis","volume":"38","author":"Mizio\u0142ek","year":"2021","journal-title":"Post. Dermatol. Alergol."},{"issue":"2 Suppl 71","key":"10.1016\/j.biopha.2023.115282_bib86","first-page":"S103","article-title":"Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis","volume":"30","author":"Pauling","year":"2012","journal-title":"Clin. Exp. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib87","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5114\/reum.2017.66686","article-title":"Infrared thermal imaging in connective tissue diseases","volume":"55","author":"Chojnowski","year":"2017","journal-title":"Reumatologia"},{"key":"10.1016\/j.biopha.2023.115282_bib88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mvr.2018.07.001","article-title":"Evidence of macro- and micro-angiopathy in scleroderma: an integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy","volume":"122","author":"Schioppo","year":"2019","journal-title":"Micro Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib89","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/acr.22965","article-title":"Vascular evaluation of the hand by power doppler ultrasonography and new predictive markers of ischemic digital ulcers in systemic sclerosis: results of a prospective pilot study","volume":"69","author":"Lescoat","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib90","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/acr.23413","article-title":"Combination of capillaroscopic and ultrasonographic evaluations in systemic sclerosis: results of a cross-sectional study","volume":"70","author":"Lescoat","year":"2018","journal-title":"Arthritis Care Res."},{"issue":"11","key":"10.1016\/j.biopha.2023.115282_bib91","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/acsnano.9b05115","article-title":"Nanodelivery of mycophenolate mofetil to the organ improves transplant vasculopathy","volume":"13","author":"Uehara","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0966-3274(98)80015-4","article-title":"Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil","volume":"6","author":"Blaheta","year":"1998","journal-title":"Transpl. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115282_bib93","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.sc.3101512","article-title":"Inhibition of monocyte\/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil","volume":"41","author":"Glomsda","year":"2003","journal-title":"Spinal Cord."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib95","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat. Rev. Rheuma"},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib96","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jid.2018.11.016","article-title":"Cyclophosphamide pulse therapy normalizes vascular abnormalities in a mouse model of systemic sclerosis vasculopathy","volume":"139","author":"Yamashita","year":"2019","journal-title":"J. Invest Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib97","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3899\/jrheum.180441","article-title":"Cyclophosphamide for systemic sclerosis-related interstitial lung disease: a comparison of scleroderma lung study I and II","volume":"46","author":"Volkmann","year":"2019","journal-title":"J. Rheuma"},{"issue":"10","key":"10.1016\/j.biopha.2023.115282_bib98","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir. Med"},{"issue":"7","key":"10.1016\/j.biopha.2023.115282_bib99","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1164\/rccm.202103-0714OC","article-title":"Long-term safety and efficacy of tocilizumab in early systemic sclerosis-interstitial lung disease: open-label extension of a phase 3 randomized controlled trial","volume":"205","author":"Khanna","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2 Suppl 76","key":"10.1016\/j.biopha.2023.115282_bib101","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin. Exp. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semarthrit.2010.08.004","article-title":"Pulmonary hypertension in systemic sclerosis","volume":"41","author":"Chatterjee","year":"2011","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib103","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14397595.2019.1704125","article-title":"The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"31","author":"Lei","year":"2021","journal-title":"Mod. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib104","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1038\/s41598-017-06350-5","article-title":"Inhibition of phosphodiesterase-5 suppresses calcineurin\/NFAT- mediated TRPC6 expression in pulmonary artery smooth muscle cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115282_bib105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/BOR.0000000000000877","article-title":"Practical management of Raynaud's phenomenon - a primer for practicing physicians","volume":"34","author":"Ramahi","year":"2022","journal-title":"Curr. Opin. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib106","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tips.2017.03.003","article-title":"Targeting the prostacyclin pathway: beyond pulmonary arterial hypertension","volume":"38","author":"Pluchart","year":"2017","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115282_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106336","article-title":"Intravenous prostacyclin-analogue therapy in pulmonary arterial hypertension - a review of the past, present and future","volume":"179","author":"Stubbe","year":"2021","journal-title":"Respir. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115282_bib108","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02493-2016","article-title":"Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension","volume":"50","author":"Gaine","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.biopha.2023.115282_bib109","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.40242","article-title":"Efficacy and safety of selexipag in adults with raynaud's phenomenon secondary to systemic sclerosis: a randomized, placebo-controlled, phase II study","volume":"69","author":"Denton","year":"2017","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2023.115282_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.biopha.2023.115282_bib111","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","author":"Cole","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib112","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.biopha.2023.115282_bib113","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases","volume":"54","author":"Wollin","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"26","key":"10.1016\/j.biopha.2023.115282_bib114","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4252\/wjsc.v13.i1.30","article-title":"Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis","volume":"13","author":"Rosa","year":"2021","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2023.115282_bib116","doi-asserted-by":"crossref","DOI":"10.1177\/0963689721997799","article-title":"Deciphering the emerging roles of adipocytes and adipose-derived stem cells in fat transplantation","volume":"30","author":"Yi","year":"2021","journal-title":"Cell Transpl."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib117","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00266-020-01848-2","article-title":"Autologous fat grafting for the oral and digital complications of systemic sclerosis: results of a prospective study","volume":"44","author":"Pignatti","year":"2020","journal-title":"Aesthetic Plast. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","article-title":"Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study","volume":"21","author":"Del Papa","year":"2019","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115282_bib119","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/rheumatology\/keab584","article-title":"Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosis","volume":"61","author":"Daumas","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/key339","article-title":"Clinical significance of Janus Kinase inhibitor selectivity","volume":"58","author":"Choy","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2023.115282_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.859330","article-title":"JAK1\/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis","volume":"9","author":"Hou","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"issue":"17","key":"10.1016\/j.biopha.2023.115282_bib123","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159566","article-title":"Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial","volume":"7","author":"Khanna","year":"2022","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.biopha.2023.115282_bib124","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/CIRCULATIONAHA.117.030423","article-title":"Inhibition of JAK-STAT signaling suppresses pathogenic immune responses in medium and large vessel vasculitis","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/art.39818","article-title":"Tofacitinib ameliorates murine lupus and its associated vascular dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115282_bib126","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"12","author":"Hasni","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2023.115282_bib127","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/annrheumdis-2015-208857","article-title":"Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohort","volume":"75","author":"Lambrecht","year":"2016","journal-title":"Ann. Rheum. Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:44:06Z","timestamp":1782369846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223010739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":127,"alternative-id":["S0753332223010739"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115282","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further insight into systemic sclerosis from the vasculopathy perspective","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115282"}}